Expression and processing of the human immunodeficiency virus type 1 envelope glycoprotein

Area of Science:

• Virology
• Molecular Biology
• Immunology

Background:

• The human immunodeficiency virus type 1 (HIV-1) envelope protein (Env) is critical for viral entry and a key target for vaccines.
• Understanding the processing of the HIV-1 Env precursor (gp160) into mature subunits (gp120 and gp41) is essential for vaccine development.

Purpose of the Study:

• To investigate the expression and processing of the HIV-1 Env protein using a vaccinia virus vector.
• To assess the impact of culture conditions and viral coinfection on gp160 processing.

Main Methods:

• Expression of HIV-1 Env using a vaccinia virus vector with the late P11 promoter.
• Analysis of syncytia formation with SupT1 cells.
• Assessment of gp160 cleavage into gp120 and gp41 in CV-1 cells.
• Evaluation of processing under altered culture media and heterologous vesicular stomatitis virus coinfection.

Main Results:

• The vaccinia vector successfully expressed the HIV-1 Env protein.
• Synthesized Env protein mediated syncytia formation, indicating functional activity.
• Efficient proteolytic cleavage of the gp160 precursor into mature gp120 and gp41 was observed.
• gp160 processing remained unaffected by changes in culture medium or coinfection with vesicular stomatitis virus.

Conclusions:

• Proteolytic cleavage of the HIV-1 gp160 precursor is an efficient process when expressed via a vaccinia vector.
• Coinfection with other viruses is unlikely to significantly alter HIV-1 Env precursor processing.
• These findings support the use of vaccinia vectors for HIV-1 vaccine research and development.